Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Acceleron Pharma Inc. (XLRN)

« Back to company index

XLRN Chatter Timeline

Stock Ticker for XLRN

Most Active Tweeters for XLRN

UserTweets
@j_jccnidan 29
@MareaInformativ 13
@whatsonthorold2 10
@AmericanBanking 10
@ZolmaxNews 9

Recent Tweets for XLRN

MareaInformativ @MareaInformativ
Acceleron Pharma $XLRN Rating Reiterated by Royal Bank of Canada https://t.co/8ZAZ6tmU5m
July 15th 2018, 12:07pm
MareaInformativ @MareaInformativ
Acceleron Pharma’s $XLRN Hold Rating Reaffirmed at Royal Bank of Canada https://t.co/w4xRdiv7Lp
July 15th 2018, 12:07pm
EnterpriseLeade @EnterpriseLeade
Acceleron Pharma $XLRN Stock Rating Reaffirmed by MED https://t.co/gvBRtmbEvs
July 15th 2018, 11:07am
EnterpriseLeade @EnterpriseLeade
Acceleron Pharma’s $XLRN Hold Rating Reaffirmed at Royal Bank of Canada https://t.co/hrqhsS4FG8
July 15th 2018, 11:07am
MareaInformativ @MareaInformativ
Acceleron Pharma’s $XLRN Hold Rating Reiterated at Royal Bank of Canada https://t.co/3UnvR87u5i
July 15th 2018, 11:07am
AmericanBanking @AmericanBanking
Acceleron Pharma Inc $XLRN Receives Average Recommendation of “Buy” from Analysts https://t.co/7Eyh8KToDd #stocks
July 15th 2018, 9:07am
ConsumerFeed @ConsumerFeed
Acceleron Pharma Inc $XLRN Given Average Rating of “Buy” by Brokerages https://t.co/wUGyK0pBdp
July 15th 2018, 9:07am
MareaInformativ @MareaInformativ
Acceleron Pharma Inc $XLRN Receives Average Recommendation of “Buy” from Analysts https://t.co/JVPlskMN2G
July 15th 2018, 9:07am
dailypoliticaln @dailypoliticaln
Acceleron Pharma $XLRN Stock Rating Reaffirmed by Cann https://t.co/N1amyH2Gjg
July 15th 2018, 5:07am
ZolmaxNews @ZolmaxNews
Acceleron Pharma’s $XLRN Hold Rating Reaffirmed at Cann https://t.co/F3hqpELDsl
July 15th 2018, 5:07am
AmericanBanking @AmericanBanking
Acceleron Pharma $XLRN Stock Rating Reaffirmed by MED https://t.co/IA3ni8kyTa #stocks
July 15th 2018, 4:07am
TranscriptDaily @TranscriptDaily
Zacks: Brokerages Anticipate Acceleron Pharma Inc $XLRN to Post -$0.61 EPS https://t.co/YQHPxQ7IVk
July 15th 2018, 4:07am
AmericanBanking @AmericanBanking
Acceleron Pharma $XLRN Downgraded to Equal Weight at Morgan Stanley https://t.co/vd0xSRbKz1 #stocks
July 15th 2018, 4:07am
ledgerzette @ledgerzette
Acceleron Pharma $XLRN Given New $62.00 Price Target at UBS Group https://t.co/EtyCUaDmuD
July 15th 2018, 3:07am
dispatchtribune @dispatchtribune
Piper Jaffray Companies Lowers Acceleron Pharma $XLRN to Neutral https://t.co/pEL9p6QkTW
July 15th 2018, 3:07am
ConsumerFeed @ConsumerFeed
HC Wainwright Increases Acceleron Pharma $XLRN Price Target to $74.00 https://t.co/OGnOOuy5hp
July 15th 2018, 3:07am
ledgerzette @ledgerzette
Acceleron Pharma’s $XLRN Hold Rating Reiterated at Royal Bank of Canada https://t.co/9ZyjUQMjYj
July 15th 2018, 2:07am
TickerReport @TickerReport
Acceleron Pharma $XLRN Rating Reiterated by Royal Bank of Canada https://t.co/aqZLTFSevd
July 15th 2018, 1:07am
dailypoliticaln @dailypoliticaln
Acceleron Pharma $XLRN Earns “Hold” Rating from Royal Bank of Canada https://t.co/GmtUz4oSgc
July 15th 2018, 1:07am
MareaInformativ @MareaInformativ
Acceleron Pharma $XLRN Stock Rating Reaffirmed by Cann https://t.co/P3Xd2Lu2Gs
July 15th 2018, 12:07am
WeekHerald @WeekHerald
Acceleron Pharma $XLRN Downgraded to “Equal Weight” at Morgan Stanley https://t.co/6t1OC7wiqj
July 15th 2018, 12:07am
dispatchtribune @dispatchtribune
Acceleron Pharma $XLRN Receives Positive Rating from MED https://t.co/tYbhQjDUsc
July 15th 2018, 12:07am
ThisLincolnian @ThisLincolnian
Acceleron Pharma $XLRN Downgraded by Morgan Stanley https://t.co/DjqYj2O8tq
July 15th 2018, 12:07am
OlympiaReport @OlympiaReport
Acceleron Pharma $XLRN Receives Positive Rating from MED https://t.co/MtGKLqPnLq
July 15th 2018, 12:07am
dailypoliticaln @dailypoliticaln
Acceleron Pharma’s $XLRN Hold Rating Reaffirmed at Cann https://t.co/v5kMULKW6L
July 14th 2018, 11:07pm
ZolmaxNews @ZolmaxNews
Cann Reaffirms Hold Rating for Acceleron Pharma $XLRN https://t.co/pD1xOG3rnu
July 14th 2018, 11:07pm
MareaInformativ @MareaInformativ
Brokerages Expect Acceleron Pharma Inc $XLRN to Post -$0.61 Earnings Per Share https://t.co/oJXSVwfS6T
July 14th 2018, 8:07pm
tgtxdough @tgtxdough
$XLRN catalysts Complete luspatercept PhIII data presented at ASH Data in Part 2 of Phase 2 ACE-083 trial in FSHD i… https://t.co/UBSqiKhIqt
July 14th 2018, 5:07pm
ConsumerFeed @ConsumerFeed
Acceleron Pharma $XLRN Given “Positive” Rating at MED https://t.co/DYnMWmY4zX
July 14th 2018, 4:07pm
MareaInformativ @MareaInformativ
Acceleron Pharma $XLRN Rating Lowered to Equal Weight at Morgan Stanley https://t.co/qhDCvoQi4s
July 14th 2018, 3:07pm
ZolmaxNews @ZolmaxNews
Acceleron Pharma $XLRN Rating Lowered to Equal Weight at Morgan Stanley https://t.co/7EMaA0mhpP
July 14th 2018, 3:07pm
HCWCO @HCWCO
On July 12 before the market opened, $XLRN announced it received #FDA #orphandrug designation for ACE-083. Click he… https://t.co/ULqLHboNdk
July 13th 2018, 10:07pm
bibeypost_stock @bibeypost_stock
Are Acceleron Pharma $XLRN Shares a Sell Now? Morgan Stanley Has Downgraded Stock - https://t.co/3NeCYkTSZX
July 13th 2018, 3:07pm
reurope_stock @reurope_stock
Acceleron Pharma $XLRN Is a Company that Morgan Stanley Seems to Dislike as Downgrade in Given https://t.co/DKtEDnCZXo
July 13th 2018, 3:07pm
mmahotstuff1 @mmahotstuff1
Acceleron Pharma $XLRN Receives Downgrade From Morgan Stanley. Will Other Analysts Follow Suit? - https://t.co/cIif4QFjjM
July 13th 2018, 3:07pm
whatsonthorold2 @whatsonthorold2
Acceleron Pharma $XLRN Loses Overweight Rating - https://t.co/pMPKhPNiIk
July 13th 2018, 3:07pm
bibeypost_stock @bibeypost_stock
Is Acceleron Pharma $XLRN In Trouble? Morgan Stanley Issues Downgrade. - https://t.co/DDeIy9NDLn
July 13th 2018, 2:07pm
mmahotstuff1 @mmahotstuff1
Acceleron Pharma $XLRN Receives Downgrade From Morgan Stanley. Will Other Analysts Follow Suit? - https://t.co/vF70W3em1L
July 13th 2018, 2:07pm
whatsonthorold2 @whatsonthorold2
Just How Negative is Morgan Stanley Following Their Downgrade of Acceleron Pharma $XLRN? - https://t.co/3KJuLwIreA
July 13th 2018, 2:07pm
j_jccnidan @j_jccnidan
$XLRN Bogus downgrade just look at the volume
July 13th 2018, 2:07pm
usratings @usratings
Morgan Stanley downgrades $XLRN from Overweight to Equal-Weight https://t.co/cJ06I1mcBU
July 13th 2018, 10:07am
j_jccnidan @j_jccnidan
$XLRN As the price gets lower Celgene becomes more interested....Don’t get shaken out by these crooked analysts
July 13th 2018, 9:07am
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $XLRN is $-0.64 it's -1.36% of the current price https://t.co/wB8VJQrjbz
July 13th 2018, 8:07am
MareaInformativ @MareaInformativ
Acceleron Pharma Inc $XLRN Expected to Announce Quarterly Sales of $3.41 Million https://t.co/OoOywCJgWt
July 13th 2018, 6:07am
Biorunner1 @Biorunner1
$XLRN MS goes "equal weight"-maintains $50 PT
July 13th 2018, 5:07am
j_jccnidan @j_jccnidan
$XLRN As the stock price becomes more stable the Celgene buyout becomes more of a possibility
July 13th 2018, 5:07am
WeekHerald @WeekHerald
Acceleron Pharma $XLRN Rating Lowered to Neutral at Piper Jaffray Companies https://t.co/ZsxS688ZHs
July 13th 2018, 4:07am
OlympiaReport @OlympiaReport
Acceleron Pharma $XLRN Cut to “Neutral” at Piper Jaffray Companies https://t.co/F2lI0PcoVM
July 13th 2018, 4:07am
ledgerzette @ledgerzette
$3.41 Million in Sales Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/aFtJn8OmQv
July 13th 2018, 1:07am
AmericanBanking @AmericanBanking
Acceleron Pharma Inc $XLRN Expected to Announce Quarterly Sales of $3.41 Million https://t.co/TxZOV9jSOX #stocks
July 13th 2018, 1:07am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.